The mitral valve is composed of the mitral valve annulus, mitral valve leaflets, chordae tendineae and papillary muscles. One part of the mitral valve leaflet including the anterior and posterior leaflets is connected to the mitral valve annulus, and the other end is connected to the chordae tendineae, while the chordae tendineae is connected to the mitral valve annulus. It is connected to the papillary muscle and constitutes the structural integrity of the mitral valve. The integrity of mitral valve function requires that the size of the mitral valve annulus is appropriate, the valve leaflet structure is complete, the papillary muscles contract and stretch the chordae tendineae to support the valve leaflets, the left ventricular muscle contraction produces appropriate closing force, and the ventricular morphology and function are normal.
Mitral Valve Intervention Market contains market size and forecasts of Mitral Valve Intervention in global, including the following market information:
- Global Mitral Valve Intervention Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Mitral Valve Intervention Market Sales, 2017-2022, 2023-2028, (K Units)
- Global top five Mitral Valve Intervention companies in 2021 (%)
The global Mitral Valve Intervention market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
- The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
- Replacement Product Segment to Reach $ Million by 2028, with a % CAGR in next six years.
- The global key manufacturers of Mitral Valve Intervention include Edwards Lifesciences, Abbott, CardioSolution, NeoChord, Mitralign, Medtronic, Boston Scientific, Mitralix and Shanghai Hanyu Medical Technology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
- We surveyed the Mitral Valve Intervention manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mitral Valve Intervention Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Mitral Valve Intervention Market Segment Percentages, by Type, 2021 (%)
- Replacement Product
- Repair Product
- Annulus Products
Global Mitral Valve Intervention Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Mitral Valve Intervention Market Segment Percentages, by Application, 2021 (%)
- Transapical
- Via Stock and Via Interstitial
- Right Internal Jugular Vein
Global Mitral Valve Intervention Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Mitral Valve Intervention Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Mitral Valve Intervention revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Mitral Valve Intervention revenues share in global market, 2021 (%)
- Key companies Mitral Valve Intervention sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Mitral Valve Intervention sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Edwards Lifesciences
- Abbott
- CardioSolution
- NeoChord
- Mitralign
- Medtronic
- Boston Scientific
- Mitralix
- Shanghai Hanyu Medical Technology
- Valgen Holding Corporation
- NeoChord
- CoreMedic
- Babic Chord
- Gore Medical
- Valtech Cardio
- Transcardiac
- ChoRe
- AVVIE
- Cardiovalve
- HighLife SAS
- Neovasc
- MitrAssist Lifesciences
- Shanghai NewMed Medical
- Peijia Medical
- MicroPort CardioFlow Medtech
Industry Market Size
